Lennon, A.M.; McMenamin, M.; Barry, H.; Keegan, D.; Purcell, H.; O'Donoghue, D.P.; Mulcahy, H.
April 2003
Gut;Apr2003 Supplement 1, Vol. 52, pA96
Academic Journal
Introduction: Cancer screening is rarely successful in populations with little knowledge of the disease being screened for. CRC screening will likely be implemented in many countries over the next 10 years, requiring accompanying educational programmes. Data are unavailable from any country on awareness and knowledge of CRC within the general population. Aim: To determine awareness and knowledge of CRC in the Irish population. Methods: A nationwide survey of 2355 adults (1250 females), comprising almost 0.1% of the entire adult population. Survey conducted in all 26 Irish regions in 2001/2002. Patients completed a questionnaire with questions on different aspects of CRC. Questions were asked about heart disease and breast cancer to provide control data. Results: Awareness of heart disease and breast cancer was high (73% and 81%, respectively had heard of these diseases in the recent past). In contrast, only 40% had heard of CRC (14% magazines/ newspapers, 12% TV/radio, 22% family/friends, 6% medical profession, 7% other sources). In relation to knowledge, 79% knew that a positive family history was associated with increased risk. However, irritabJe bowel syndrome (60%) and stress (62%) were thought to be greater risk factors for CRC than polyps (59%). 42% could name at least 1 colorectal cancer symptom, 53% thought that most patients were under 60 years of age at diagnosis, 61% were aware of surgery as a treatment, 45% estimated 5 year survival as above 40%, and 46% were aware that screening tests were available. Factors associated with CRC knowledge included having read about the disease in the recent past (p = 0.01), older age (p < 0.001), and higher educational status (p < 0.001 ). Conclusions: This nationwide survey shows that awareness and knowledge of CRC is limited, especially in certain groups. This may have important implications For the success of future screening programmes and will allow us to target certain population groups for intensive education...


Related Articles

  • Irritable bowel syndrome and the incidence of colorectal neoplasia: a prospective cohort study with community-based screened population in Taiwan. Chang, H-C; Yen, A M-F; Fann, J C-Y; Chiu, S Y-H; Liao, C-S; Chen, H-H; Yang, K-C; Chen, L-S; Lin, Y-M // British Journal of Cancer;1/6/2015, Vol. 112 Issue 1, p171 

    Background:We aim to report the prevalence of irritable bowel syndrome (IBS) and elucidate the influence of IBS on the incidence of colorectal neoplasm through a community-screening-based, longitudinal follow-up study.Methods:We enroled 39 384 community residents aged 40 years or older who had...

  • Evaluation of Patients Who Meet Clinical Criteria for Irritable Bowel Syndrome. Tolliver, Beth A.; Herrera, Jorge L.; DiPalma, Jack A. // American Journal of Gastroenterology;Feb1994, Vol. 89 Issue 2, p176 

    Objective: To determine which test would yield the most useful clinical data in evaluation of irritable bowel syndrome (IBS). Methods: One hundred ninety-six patients who met the International Congress of Gastroenterology criteria for irritable bowel syndrome were prospectively evaluated with...

  • Functional Bowel Disorders Without Tears. Dworken, Harvey J. // Annals of Internal Medicine;Nov80, Vol. 93 Issue 5, p776 

    Editorial. Reveals that gastrointestinal symptoms occurred in British adults with functional bowel disorders. Symptoms of irritable bowel syndrome; Information on procedures that must be followed when persons with symptoms of functional bowel disorders are detected in medical screening programs.

  • Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Chey, William D.; Olden, Kevin; Carter, Eric; Boyle, John; Drossman, Douglas; Chang, Lin // American Journal of Gastroenterology;Nov2002, Vol. 97 Issue 11, p2803 

    OBJECTIVES:Using interview data from a large, community-based sample of American women, we assessed the lifetime prevalence of irritable bowel syndrome (IBS) using questions consistent with the Rome II criteria, determined the sensitivity of Rome I and II in women diagnosed with IBS by their...

  • Managing irritable bowel syndrome. Horwitz, Brenda L.; Lembo, Anthony J.; Whitehead, William E. // Patient Care for the Nurse Practitioner;Feb2003, Vol. 6 Issue 2, p5 

    The article focuses on the diagnosis and management of irritable bowel syndrome (IBS). The syndrome is suggested by the presence of lower abdominal pain associated with disordered defecation that is not caused by structural or metabolic abnormalities. Elicit any personal or family history of...

  • The diversity of inflammatory bowel disease: beyond the gut.  // Gastrointestinal Nursing;May2012, Vol. 10 Issue 4, p22 

    Information about several issues and challenges, encountered by nurses in daily practice, discussed at the 7th National inflammatory bowel disease (IBD) Nurse Symposium, held by Ferring Pharmaceuticals on the 6-7th December 2011 at the Crowne Plaza Hotel, National Exhibition Centre, Birmingham,...

  • What's Hot in the Red Journal This Month.  // American Journal of Gastroenterology;Jan2012, Vol. 107 Issue 1, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including hepatocellular carcinoma in diabetic patients, chronic constipation in old age, and the allergic factors that can worsen diarrheic irritable bowel syndrome.

  • What's Hot in the Red Journal This Month.  // American Journal of Gastroenterology;Jul2013, Vol. 108 Issue 7, p1021 

    An introduction to a section of the periodical is presented which include articles related to nonpolypoid colorectal neoplasms (NP-CRNs), irritable bowel syndrome (IBS) and treatment of Achalasia.

  • Letters.  // Annals of Internal Medicine;12/15/92, Vol. 117 Issue 12, p1056 

    Comments on several issues related to the field of medicine. Diagnosis of the irritable bowel syndrome; Case study on acromegaly and pituitary carcinoma; Diciofenac-induced isolated myonecrosis and the Nicolau syndrome.


Read the Article


Sign out of this library

Other Topics